Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 50 entries
Sorted by: Best Match Show Resources per page
Workarounds Emerging From Electronic Health Record System Usage: Consequences for Patient Safety, Effectiveness of Care, and Efficiency of Care.

JMIR human factors

Blijleven V, Koelemeijer K, Wetzels M, Jaspers M.
PMID: 28982645
JMIR Hum Factors. 2017 Oct 05;4(4):e27. doi: 10.2196/humanfactors.7978.

BACKGROUND: Health care providers resort to informal temporary practices known as workarounds for handling exceptions to normal workflow unintendedly imposed by electronic health record systems (EHRs). Although workarounds may seem favorable at first sight, they are generally suboptimal and...

Cite
Blijleven V, Koelemeijer K, Wetzels M, et al. Workarounds Emerging From Electronic Health Record System Usage: Consequences for Patient Safety, Effectiveness of Care, and Efficiency of Care. JMIR Hum Factors. 2017;4(4):e27doi: 10.2196/humanfactors.7978.
Blijleven, V., Koelemeijer, K., Wetzels, M., & Jaspers, M. (2017). Workarounds Emerging From Electronic Health Record System Usage: Consequences for Patient Safety, Effectiveness of Care, and Efficiency of Care. JMIR human factors, 4(4), e27. https://doi.org/10.2196/humanfactors.7978
Blijleven, Vincent, et al. "Workarounds Emerging From Electronic Health Record System Usage: Consequences for Patient Safety, Effectiveness of Care, and Efficiency of Care." JMIR human factors vol. 4,4 (2017): e27. doi: https://doi.org/10.2196/humanfactors.7978
Blijleven V, Koelemeijer K, Wetzels M, Jaspers M. Workarounds Emerging From Electronic Health Record System Usage: Consequences for Patient Safety, Effectiveness of Care, and Efficiency of Care. JMIR Hum Factors. 2017 Oct 05;4(4):e27. doi: 10.2196/humanfactors.7978. PMID: 28982645; PMCID: PMC5649044.
Copy Download .nbib Format: NLM
Cytotoxicity of 2-tert-butyl hydroquinone glutathione conjugates after apical and basolateral exposure of rat renal proximal tubular cell monolayers.

Toxicology in vitro : an international journal published in association with BIBRA

Haenen HE, Bleijlevens E, Elzerman H, Temmink JH, Koeman JH, Van Bladeren PJ.
PMID: 20650192
Toxicol In Vitro. 1996 Apr;10(2):141-8. doi: 10.1016/0887-2333(95)00116-6.

Confluent monolayers of renal proximal tubular (RPT) cells cultured on porous supports were used to investigate the cytotoxicity induced by glutathione conjugates of 2-tert-butyl-(1,4)-hydroquinone (SG-TBHQ) after apical and basolateral exposure. As judged from lactate dehydrogenase (LDH) leakage, cytotoxicity was...

Cite
Haenen HE, Bleijlevens E, Elzerman H, et al. Cytotoxicity of 2-tert-butyl hydroquinone glutathione conjugates after apical and basolateral exposure of rat renal proximal tubular cell monolayers. Toxicol In Vitro. 1996;10(2):141-8doi: 10.1016/0887-2333(95)00116-6.
Haenen, H. E., Bleijlevens, E., Elzerman, H., Temmink, J. H., Koeman, J. H., & Van Bladeren, P. J. (1996). Cytotoxicity of 2-tert-butyl hydroquinone glutathione conjugates after apical and basolateral exposure of rat renal proximal tubular cell monolayers. Toxicology in vitro : an international journal published in association with BIBRA, 10(2), 141-8. https://doi.org/10.1016/0887-2333(95)00116-6
Haenen, H E, et al. "Cytotoxicity of 2-tert-butyl hydroquinone glutathione conjugates after apical and basolateral exposure of rat renal proximal tubular cell monolayers." Toxicology in vitro : an international journal published in association with BIBRA vol. 10,2 (1996): 141-8. doi: https://doi.org/10.1016/0887-2333(95)00116-6
Haenen HE, Bleijlevens E, Elzerman H, Temmink JH, Koeman JH, Van Bladeren PJ. Cytotoxicity of 2-tert-butyl hydroquinone glutathione conjugates after apical and basolateral exposure of rat renal proximal tubular cell monolayers. Toxicol In Vitro. 1996 Apr;10(2):141-8. doi: 10.1016/0887-2333(95)00116-6. PMID: 20650192.
Copy Download .nbib Format: NLM
Emerging evidence on the pathobiology of mucositis.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV.
PMID: 23604521
Support Care Cancer. 2013 Jul;21(7):2075-83. doi: 10.1007/s00520-013-1810-y. Epub 2013 Apr 21.

BACKGROUND: Considerable progress has been made in our understanding of the biological basis for cancer therapy-induced mucosal barrier injury (mucositis). The last formal review of the subject by MASCC/ISOO was published in 2007; consequently, an update is timely.METHODS: Panel...

Cite
Al-Dasooqi N, Sonis ST, Bowen JM, et al. Emerging evidence on the pathobiology of mucositis. Support Care Cancer. 2013;21(7):2075-83doi: 10.1007/s00520-013-1810-y.
Al-Dasooqi, N., Sonis, S. T., Bowen, J. M., Bateman, E., Blijlevens, N., Gibson, R. J., Logan, R. M., Nair, R. G., Stringer, A. M., Yazbeck, R., Elad, S., Lalla, R. V. (2013). Emerging evidence on the pathobiology of mucositis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 21(7), 2075-83. https://doi.org/10.1007/s00520-013-1810-y
Al-Dasooqi, Noor, et al. "Emerging evidence on the pathobiology of mucositis." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 21,7 (2013): 2075-83. doi: https://doi.org/10.1007/s00520-013-1810-y
Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV. Emerging evidence on the pathobiology of mucositis. Support Care Cancer. 2013 Jul;21(7):2075-83. doi: 10.1007/s00520-013-1810-y. Epub 2013 Apr 21. PMID: 23604521.
Copy Download .nbib Format: NLM
Impact of Oral Side Effects from Conditioning Therapy Before Hematopoietic Stem Cell Transplantation: Protocol for a Multicenter Study.

JMIR research protocols

Brennan MT, Hasséus B, Hovan AJ, Raber-Durlacher JE, Blijlevens NM, Huysmans MC, Garming Legert K, Johansson JE, Moore CG, von Bültzingslöwen I.
PMID: 29685874
JMIR Res Protoc. 2018 Apr 23;7(4):e103. doi: 10.2196/resprot.8982.

BACKGROUND: The oral cavity is a common site of complications related to the cytotoxic effect of high-dose chemotherapy and radiation therapy. Considering our limited understanding of the burden of illness in the oral cavity from various cytotoxic therapies, it...

Cite
Brennan MT, Hasséus B, Hovan AJ, et al. Impact of Oral Side Effects from Conditioning Therapy Before Hematopoietic Stem Cell Transplantation: Protocol for a Multicenter Study. JMIR Res Protoc. 2018;7(4):e103doi: 10.2196/resprot.8982.
Brennan, M. T., Hasséus, B., Hovan, A. J., Raber-Durlacher, J. E., Blijlevens, N. M., Huysmans, M. C., Garming Legert, K., Johansson, J. E., Moore, C. G., & von Bültzingslöwen, I. (2018). Impact of Oral Side Effects from Conditioning Therapy Before Hematopoietic Stem Cell Transplantation: Protocol for a Multicenter Study. JMIR research protocols, 7(4), e103. https://doi.org/10.2196/resprot.8982
Brennan, Michael T, et al. "Impact of Oral Side Effects from Conditioning Therapy Before Hematopoietic Stem Cell Transplantation: Protocol for a Multicenter Study." JMIR research protocols vol. 7,4 (2018): e103. doi: https://doi.org/10.2196/resprot.8982
Brennan MT, Hasséus B, Hovan AJ, Raber-Durlacher JE, Blijlevens NM, Huysmans MC, Garming Legert K, Johansson JE, Moore CG, von Bültzingslöwen I. Impact of Oral Side Effects from Conditioning Therapy Before Hematopoietic Stem Cell Transplantation: Protocol for a Multicenter Study. JMIR Res Protoc. 2018 Apr 23;7(4):e103. doi: 10.2196/resprot.8982. PMID: 29685874; PMCID: PMC5938569.
Copy Download .nbib Format: NLM
Cancer Survivorship Care: Person Centered Care in a Multidisciplinary Shared Care Model.

International journal of integrated care

Loonen JJ, Blijlevens NM, Prins J, Dona DJ, Den Hartogh J, Senden T, van Dulmen-Den Broeder E, van der Velden K, Hermens RP.
PMID: 29588641
Int J Integr Care. 2018 Jan 16;18(1):4. doi: 10.5334/ijic.3046.

Survivors of childhood and adult-onset cancer are at lifelong risk for the development of late effects of treatment that can lead to serious morbidity and premature mortality. Regular long-term follow-up aiming for prevention, early detection and intervention of late...

Cite
Loonen JJ, Blijlevens NM, Prins J, et al. Cancer Survivorship Care: Person Centered Care in a Multidisciplinary Shared Care Model. Int J Integr Care. 2018;18(1):4doi: 10.5334/ijic.3046.
Loonen, J. J., Blijlevens, N. M., Prins, J., Dona, D. J., Den Hartogh, J., Senden, T., van Dulmen-Den Broeder, E., van der Velden, K., & Hermens, R. P. (2018). Cancer Survivorship Care: Person Centered Care in a Multidisciplinary Shared Care Model. International journal of integrated care, 18(1), 4. https://doi.org/10.5334/ijic.3046
Loonen, Jacqueline J, et al. "Cancer Survivorship Care: Person Centered Care in a Multidisciplinary Shared Care Model." International journal of integrated care vol. 18,1 (2018): 4. doi: https://doi.org/10.5334/ijic.3046
Loonen JJ, Blijlevens NM, Prins J, Dona DJ, Den Hartogh J, Senden T, van Dulmen-Den Broeder E, van der Velden K, Hermens RP. Cancer Survivorship Care: Person Centered Care in a Multidisciplinary Shared Care Model. Int J Integr Care. 2018 Jan 16;18(1):4. doi: 10.5334/ijic.3046. PMID: 29588641; PMCID: PMC5854087.
Copy Download .nbib Format: NLM
Safety and efficacy of a Hb-triggered single-unit red cell transfusion policy for haemato-oncological inpatients.

British journal of haematology

Bosch M, de Lil HS, Oomen JJ, Eijsink C, Blijlevens NMA, Hoeks MPA, Evers D.
PMID: 34355394
Br J Haematol. 2021 Nov;195(4):e154-e156. doi: 10.1111/bjh.17748. Epub 2021 Aug 05.

No abstract available.

Cite
Bosch M, de Lil HS, Oomen JJ, et al. Safety and efficacy of a Hb-triggered single-unit red cell transfusion policy for haemato-oncological inpatients. Br J Haematol. 2021;195(4):e154-e156doi: 10.1111/bjh.17748.
Bosch, M., de Lil, H. S., Oomen, J. J., Eijsink, C., Blijlevens, N. M. A., Hoeks, M. P. A., & Evers, D. (2021). Safety and efficacy of a Hb-triggered single-unit red cell transfusion policy for haemato-oncological inpatients. British journal of haematology, 195(4), e154-e156. https://doi.org/10.1111/bjh.17748
Bosch, Milou, et al. "Safety and efficacy of a Hb-triggered single-unit red cell transfusion policy for haemato-oncological inpatients." British journal of haematology vol. 195,4 (2021): e154-e156. doi: https://doi.org/10.1111/bjh.17748
Bosch M, de Lil HS, Oomen JJ, Eijsink C, Blijlevens NMA, Hoeks MPA, Evers D. Safety and efficacy of a Hb-triggered single-unit red cell transfusion policy for haemato-oncological inpatients. Br J Haematol. 2021 Nov;195(4):e154-e156. doi: 10.1111/bjh.17748. Epub 2021 Aug 05. PMID: 34355394.
Copy Download .nbib Format: NLM
A randomized controlled trial of manual versus powered tooth brushing during haematopoietic stem cell transplantation.

Oral diseases

Potting CMJ, van Leeuwen SJM, Kurstjens MH, Bronkhorst EM, Thomas RZ, Blijlevens NMA, Huysmans MDNJM.
PMID: 33964053
Oral Dis. 2021 May 08; doi: 10.1111/odi.13899. Epub 2021 May 08.

AIM: To compare manual and powered tooth brushing (MT and PT) with respect to patient compliance to brushing frequency advice, plaque removal and severity of oral mucositis (OM) in patients undergoing hematopoietic stem cell transplantation (HSCT) after high-dose chemotherapy.MATERIALS...

Cite
Potting CMJ, van Leeuwen SJM, Kurstjens MH, et al. A randomized controlled trial of manual versus powered tooth brushing during haematopoietic stem cell transplantation. Oral Dis. 2021;doi: 10.1111/odi.13899.
Potting, C. M. J., van Leeuwen, S. J. M., Kurstjens, M. H., Bronkhorst, E. M., Thomas, R. Z., Blijlevens, N. M. A., & Huysmans, M. D. N. J. M. (2021). A randomized controlled trial of manual versus powered tooth brushing during haematopoietic stem cell transplantation. Oral diseases, . https://doi.org/10.1111/odi.13899
Potting, Carin M J, et al. "A randomized controlled trial of manual versus powered tooth brushing during haematopoietic stem cell transplantation." Oral diseases vol. (2021). doi: https://doi.org/10.1111/odi.13899
Potting CMJ, van Leeuwen SJM, Kurstjens MH, Bronkhorst EM, Thomas RZ, Blijlevens NMA, Huysmans MDNJM. A randomized controlled trial of manual versus powered tooth brushing during haematopoietic stem cell transplantation. Oral Dis. 2021 May 08; doi: 10.1111/odi.13899. Epub 2021 May 08. PMID: 33964053.
Copy Download .nbib Format: NLM
Manufacturers' views on outcome-based agreements.

Journal of market access & health policy

Barjestehvan Waalwijk van Doorn-Khosrovani S, Timmers L, Pisters-van Roy A, Gijzen J, Blijlevens NMA, Bloemendal H.
PMID: 34745459
J Mark Access Health Policy. 2021 Oct 29;9(1):1993593. doi: 10.1080/20016689.2021.1993593. eCollection 2021.

INTRODUCTION: Outcome-based agreements (OBAs) are occasionally deployed to relieve the burden of high drug prices on healthcare budgets. However, it is not clear when manufacturers are willing to collaborate in establishing such agreements. Therefore, we explored the feasibility of...

Cite
Barjestehvan Waalwijk van Doorn-Khosrovani S, Timmers L, Pisters-van Roy A, et al. Manufacturers' views on outcome-based agreements. J Mark Access Health Policy. 2021;9(1):1993593doi: 10.1080/20016689.2021.1993593.
Barjestehvan Waalwijk van Doorn-Khosrovani, S., Timmers, L., Pisters-van Roy, A., Gijzen, J., Blijlevens, N. M. A., & Bloemendal, H. (2021). Manufacturers' views on outcome-based agreements. Journal of market access & health policy, 9(1), 1993593. https://doi.org/10.1080/20016689.2021.1993593
Barjestehvan Waalwijk van Doorn-Khosrovani, Sahar, et al. "Manufacturers' views on outcome-based agreements." Journal of market access & health policy vol. 9,1 (2021): 1993593. doi: https://doi.org/10.1080/20016689.2021.1993593
Barjestehvan Waalwijk van Doorn-Khosrovani S, Timmers L, Pisters-van Roy A, Gijzen J, Blijlevens NMA, Bloemendal H. Manufacturers' views on outcome-based agreements. J Mark Access Health Policy. 2021 Oct 29;9(1):1993593. doi: 10.1080/20016689.2021.1993593. eCollection 2021. PMID: 34745459; PMCID: PMC8567951.
Copy Download .nbib Format: NLM
Filling the gaps of patient information needs and information perception in chronic myeloid leukemia with the patient-physician co-produced web-based platform CMyLife.

Patient education and counseling

Ector GI, Verweij L, Hermens RP, Blijlevens NM.
PMID: 34226069
Patient Educ Couns. 2021 Jun 27; doi: 10.1016/j.pec.2021.06.025. Epub 2021 Jun 27.

BACKGROUND: For patients with chronic myeloid leukemia, a web-based platform CMyLife was developed. Its aim is to enhance patient empowerment, by adequate information provision, among others. Before evaluating its effect, information provision and needs in current care were assessed.OBJECTIVE:...

Cite
Ector GI, Verweij L, Hermens RP, et al. Filling the gaps of patient information needs and information perception in chronic myeloid leukemia with the patient-physician co-produced web-based platform CMyLife. Patient Educ Couns. 2021;doi: 10.1016/j.pec.2021.06.025.
Ector, G. I., Verweij, L., Hermens, R. P., & Blijlevens, N. M. (2021). Filling the gaps of patient information needs and information perception in chronic myeloid leukemia with the patient-physician co-produced web-based platform CMyLife. Patient education and counseling, . https://doi.org/10.1016/j.pec.2021.06.025
Ector, Geneviève Icg, et al. "Filling the gaps of patient information needs and information perception in chronic myeloid leukemia with the patient-physician co-produced web-based platform CMyLife." Patient education and counseling vol. (2021). doi: https://doi.org/10.1016/j.pec.2021.06.025
Ector GI, Verweij L, Hermens RP, Blijlevens NM. Filling the gaps of patient information needs and information perception in chronic myeloid leukemia with the patient-physician co-produced web-based platform CMyLife. Patient Educ Couns. 2021 Jun 27; doi: 10.1016/j.pec.2021.06.025. Epub 2021 Jun 27. PMID: 34226069.
Copy Download .nbib Format: NLM
Nurse-led video-coaching interventions in childhood, adolescent and young adult cancer survivors (REVIVER): a protocol for mixed methods feasibility research.

Pilot and feasibility studies

Bouwman E, Hermens RPMG, Blijlevens NMA, Prins JB, Loonen JJ.
PMID: 31890262
Pilot Feasibility Stud. 2019 Dec 18;5:150. doi: 10.1186/s40814-019-0535-1. eCollection 2019.

BACKGROUND: Successful cancer treatment can lead to cancer survivors being predisposed to an increased lifelong risk of adverse late health effects. Therefore, high-quality cancer survivorship care to earlier detect and treat late effects or to preserve survivor's health is...

Cite
Bouwman E, Hermens RPMG, Blijlevens NMA, et al. Nurse-led video-coaching interventions in childhood, adolescent and young adult cancer survivors (REVIVER): a protocol for mixed methods feasibility research. Pilot Feasibility Stud. 2019;5:150doi: 10.1186/s40814-019-0535-1.
Bouwman, E., Hermens, R. P. M. G., Blijlevens, N. M. A., Prins, J. B., & Loonen, J. J. (2019). Nurse-led video-coaching interventions in childhood, adolescent and young adult cancer survivors (REVIVER): a protocol for mixed methods feasibility research. Pilot and feasibility studies, 5150. https://doi.org/10.1186/s40814-019-0535-1
Bouwman, Eline, et al. "Nurse-led video-coaching interventions in childhood, adolescent and young adult cancer survivors (REVIVER): a protocol for mixed methods feasibility research." Pilot and feasibility studies vol. 5 (2019): 150. doi: https://doi.org/10.1186/s40814-019-0535-1
Bouwman E, Hermens RPMG, Blijlevens NMA, Prins JB, Loonen JJ. Nurse-led video-coaching interventions in childhood, adolescent and young adult cancer survivors (REVIVER): a protocol for mixed methods feasibility research. Pilot Feasibility Stud. 2019 Dec 18;5:150. doi: 10.1186/s40814-019-0535-1. eCollection 2019. PMID: 31890262; PMCID: PMC6921525.
Copy Download .nbib Format: NLM
Densities in the left innominate vein after removal of an implantable venous device: a case report.

Journal of medical case reports

van Bastelaar J, Janssen CH, de Bont E, Blijlevens NM, van Baren R.
PMID: 22747780
J Med Case Rep. 2012 Jul 02;6:180. doi: 10.1186/1752-1947-6-180.

INTRODUCTION: Pericatheter calcifications are unusual and rare after removal of indwelling central venous catheters with few reports in the literature. We present a case of a woman with calcifications in her left innominate vein after removal of an implantable...

Cite
van Bastelaar J, Janssen CH, de Bont E, et al. Densities in the left innominate vein after removal of an implantable venous device: a case report. J Med Case Rep. 2012;6:180doi: 10.1186/1752-1947-6-180.
van Bastelaar, J., Janssen, C. H., de Bont, E., Blijlevens, N. M., & van Baren, R. (2012). Densities in the left innominate vein after removal of an implantable venous device: a case report. Journal of medical case reports, 6180. https://doi.org/10.1186/1752-1947-6-180
van Bastelaar, James, et al. "Densities in the left innominate vein after removal of an implantable venous device: a case report." Journal of medical case reports vol. 6 (2012): 180. doi: https://doi.org/10.1186/1752-1947-6-180
van Bastelaar J, Janssen CH, de Bont E, Blijlevens NM, van Baren R. Densities in the left innominate vein after removal of an implantable venous device: a case report. J Med Case Rep. 2012 Jul 02;6:180. doi: 10.1186/1752-1947-6-180. PMID: 22747780; PMCID: PMC3407751.
Copy Download .nbib Format: NLM
Risk of infectious complications in adult patients after allogeneic hematopoietic stem cell transplantation depending on the site of central venous catheter insertion-multicenter prospective observational study, from the IDWP EBMT and Nurses Group of EBMT.

Bone marrow transplantation

Snarski E, Stringer J, Mikulska M, Gil L, Tridello G, Bosman P, Lippinkhof A, Hoek J, Karas M, Zver S, Lueck C, Blijlevens N, González I, Ociepa-Wasilkowska M, Górka M, Sánchez-Ortega I, Andersson I, Yáñez L, Bekadja MA, Styczynski J.
PMID: 34420041
Bone Marrow Transplant. 2021 Dec;56(12):2929-2933. doi: 10.1038/s41409-021-01430-7. Epub 2021 Aug 21.

The current guidelines for prevention of infections in hematopoietic stem cell transplantation (HSCT) do not specify which central venous catheter (CVC) insertion site should be preferred in allogeneic HSCT recipients-internal jugular vein (IJV) or subclavian vein (SCV). We designed...

Cite
Snarski E, Stringer J, Mikulska M, et al. Risk of infectious complications in adult patients after allogeneic hematopoietic stem cell transplantation depending on the site of central venous catheter insertion-multicenter prospective observational study, from the IDWP EBMT and Nurses Group of EBMT. Bone Marrow Transplant. 2021;56(12):2929-2933doi: 10.1038/s41409-021-01430-7.
Snarski, E., Stringer, J., Mikulska, M., Gil, L., Tridello, G., Bosman, P., Lippinkhof, A., Hoek, J., Karas, M., Zver, S., Lueck, C., Blijlevens, N., González, I., Ociepa-Wasilkowska, M., Górka, M., Sánchez-Ortega, I., Andersson, I., Yáñez, L., Bekadja, M. A., & Styczynski, J. (2021). Risk of infectious complications in adult patients after allogeneic hematopoietic stem cell transplantation depending on the site of central venous catheter insertion-multicenter prospective observational study, from the IDWP EBMT and Nurses Group of EBMT. Bone marrow transplantation, 56(12), 2929-2933. https://doi.org/10.1038/s41409-021-01430-7
Snarski, Emilian, et al. "Risk of infectious complications in adult patients after allogeneic hematopoietic stem cell transplantation depending on the site of central venous catheter insertion-multicenter prospective observational study, from the IDWP EBMT and Nurses Group of EBMT." Bone marrow transplantation vol. 56,12 (2021): 2929-2933. doi: https://doi.org/10.1038/s41409-021-01430-7
Snarski E, Stringer J, Mikulska M, Gil L, Tridello G, Bosman P, Lippinkhof A, Hoek J, Karas M, Zver S, Lueck C, Blijlevens N, González I, Ociepa-Wasilkowska M, Górka M, Sánchez-Ortega I, Andersson I, Yáñez L, Bekadja MA, Styczynski J. Risk of infectious complications in adult patients after allogeneic hematopoietic stem cell transplantation depending on the site of central venous catheter insertion-multicenter prospective observational study, from the IDWP EBMT and Nurses Group of EBMT. Bone Marrow Transplant. 2021 Dec;56(12):2929-2933. doi: 10.1038/s41409-021-01430-7. Epub 2021 Aug 21. PMID: 34420041.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 50 entries